Main content
Early Phase Cancer Research in the COVID-19 Pandemic: an ECMC North Initiative /
First in Human: Who and what makes a cancer phase 1 trial and why are they so important?
- Gaston Welisch
- Chris Twelves
- Ruth Plummer
- Jeff Evans
- Sarah Danson
- Stefan Symeonides
- Chris Halsey
- Rob Jones
- Catherine Hanna
- Peter Gallagher
- Gerard Walls
- Kirsty Taylor
- Shelby Barnett
- Caroline Forde
- Mark White
- Chris Williams
- Salma El Badri
- Bong'eni David Chipole
- Nicol Keith
Date created: | Last Updated:
: DOI | ARK
Creating DOI. Please wait...
Category: Project
Description: Bringing new cancer therapies into routine cancer care is a long and complex process. Phase 1 clinical trials assess new cancer treatments in people for the first time. It is a critical step in the pathway. The aim of this project is to make the world of a cancer Phase 1 trialist and the value they bring, understandable to others. From those interested in careers in cancer clinical trials to stakeholders and partners seeking to innovate across the cancer control continuum, through a deeper understanding and insight of those involved.
Add important information, links, or images here to describe your project.